title: Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease.
abstract: OBJECTIVE
  Genetic variation in the chromosome 5q31 cytokine cluster (IBD5 risk haplotype) has been associated with Crohn's disease (CD) in a Canadian population. We studied the IBD5 risk haplotype in both British and Japanese cohorts. Disease associations have also been reported for CARD15/NOD2 and TNF variants. Complex interactions between susceptibility loci have been shown in animal models, and we tested for potential gene-gene interactions between the three CD associated loci.
  
  
  METHODS
  Family based association analyses were performed in 457 British families (252 ulcerative colitis, 282 CD trios) genotyped for the IBD5 haplotype, common CARD15, and TNF-857 variants. To test for possible epistatic interactions between variants, transmission disequilibrium test analyses were further stratified by genotype at other loci, and novel log linear analyses were performed using the haplotype relative risk model. Case control association analyses were performed in 178 Japanese CD patients and 156 healthy controls genotyped for the IBD5 haplotype.
  
  
  RESULTS
  The IBD5 haplotype was associated with CD (p=0.007), but not with UC, in the British Caucasian population. The CARD15 variants and IBD5 haplotype showed additive main effects, and in particular no evidence for epistatic interactions was found. Variants from the IBD5 haplotype were extremely rare in the Japanese.
  
  
  CONCLUSIONS
  The IBD5 risk haplotype is associated with British CD. Genetic variants predisposing to CD show heterogeneity and population specific differences.
authors.affiliation: Wellcome Trust Centre for Human Genetics, University of Oxford, UK. Tohoku University Graduate School of Medicine, Sendai, Japan. Oxagen Ltd, Abingdon, UK. Gastroenterology Unit, University of Oxford, UK.
authors.forename: K
authors.initials: K
authors.lastname: Negoro
authors.forename: D P B
authors.initials: DP
authors.lastname: McGovern
authors.forename: Y
authors.initials: Y
authors.lastname: Kinouchi
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
authors.forename: N J
authors.initials: NJ
authors.lastname: Lench
authors.forename: T
authors.initials: T
authors.lastname: Shimosegawa
authors.forename: A
authors.initials: A
authors.lastname: Carey
authors.forename: L R
authors.initials: LR
authors.lastname: Cardon
authors.forename: D P
authors.initials: DP
authors.lastname: Jewell
authors.forename: D A
authors.initials: DA
authors.lastname: van Heel
mesh_terms: D000328:Adult; D002170:Canada; D002352:Carrier Proteins / Q000235:genetics; D016022:Case-Control Studies; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D003093:Colitis, Ulcerative / Q000208:ethnology / Q000235:genetics; D003424:Crohn Disease / Q000208:ethnology / Q000235:genetics*; D004843:Epistasis, Genetic; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D007564:Japan; D008297:Male; D053473:Nod2 Signaling Adaptor Protein; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics; D006113:United Kingdom
chemical_list: D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D014409:Tumor Necrosis Factor-alpha